Help navigating care for liver cancer patients
Part of Cancer, Digestive system clinical trials.
This trial looks at how to guide people with hepatocellular carcinoma (a type of liver cancer) through the study process. It may help you by explaining what to expect and supporting you in following required study steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of hepatocellular carcinoma (primary liver cancer).
- You are willing to do all required study visits, tests, and follow-up steps.
- You can sign an informed consent form and follow all study rules and restrictions.
- You should not have serious or unstable medical problems that could interfere with safety.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve how patients with liver cancer (hepatocellular carcinoma) get the support and information they need. Researchers will interview patients, caregivers, and healthcare providers to find better ways to navigate care.
This study reviews medical records of people diagnosed with hepatocellular carcinoma (liver cancer) between 2015 and 2023 to better understand how the disease progresses and how different treatments work. Your information helps researchers learn what care approaches work best for future patients.
This trial looks at overall survival (how long people live) in real-world patients with unresectable liver cancer. It may help researchers understand outcomes outside of tightly controlled studies.
This study follows people with hepatocellular carcinoma (HCC), a type of liver cancer, to learn how it changes over time. It may help improve understanding of which patients benefit from different care approaches.
This trial aims to discover new immune system targets on liver cancer cells and other tumors to develop better immunotherapies. Researchers will analyze tumor samples to find these targets, which could lead to more effective treatments.
This study follows people with bile duct cancer or certain liver cancers to better understand their disease. You might be included if you meet the diagnosis and basic participation requirements.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.